Motor Endplate Disorders Myasthenia Gravis Overview and Definition
Myasthenia gravis is an autoimmune disorder characterized by fluctuating weakness and fatigability of skeletal muscles. It is caused by antibodies that impair signaling at the neuromuscular junction, reducing efficiency of muscle contraction. Symptoms include drooping eyelids, double vision, difficulty chewing/swallowing and generalized weakness exacerbated by activity. Diagnosis involves testing for antibodies, response to medication, and electrophysiology. Treatment focuses on acetylcholinesterase inhibitors, immunosuppression, plasmapheresis and sometimes thymectomy to relieve symptoms, though the underlying cause remains unknown.
Motor Endplate Disorders Myasthenia Gravis Overview and Definition
Myasthenia gravis is an autoimmune disorder characterized by fluctuating weakness and fatigability of skeletal muscles. It is caused by antibodies that impair signaling at the neuromuscular junction, reducing efficiency of muscle contraction. Symptoms include drooping eyelids, double vision, difficulty chewing/swallowing and generalized weakness exacerbated by activity. Diagnosis involves testing for antibodies, response to medication, and electrophysiology. Treatment focuses on acetylcholinesterase inhibitors, immunosuppression, plasmapheresis and sometimes thymectomy to relieve symptoms, though the underlying cause remains unknown.
MOTOR ENDPLATE DISORDERS flattened, which results in decreased efficiency
Myasthenia Gravis of neuromuscular transmission. The
Overview and Definition neuromuscular junction can normally transmit Myasthenia gravis (MG) is the most at high frequencies so that the muscle does not common of the disorders of neuromuscular fatigue. Without ACh, the nerve impulses fail to transmission. It is characterized by fluctuating pass across the neuromuscular junction to weakness and fatigability of skeletal muscles. stimulate muscle contraction. The neuromuscular abnormalities in MG are brought Incidence about by an autoimmune response mediated by The incidence of MG is estimated at specific anti-ACh receptor antibodies. The 1:200,000. Estimates from the National antibodies may block the site that normally Myasthenia Gravis Foundation are that there are binds ACh, or the antibodies may damage the over 100,000 clients with MG and an additional postsynaptic muscle membrane. There may be 25,000 undiagnosed cases. MG can affect people endocytosis (pinching off of regions of the cell's in any age group, but peak incidences occur in membrane) of the receptor site. women in their twenties and thirties and in men Although the cause of the autoimmune in their fifties and sixties. Overall, the ratio of response in MG is not well understood, the women affected compared to men is 3:2. thymus appears to play a role in the disease; 7 5 % of persons with MG have abnormalities of the Etiology thymus (e.g., thymic hyperplasia or thymoma). MG is an autoimmune disorder whose Cells within the thymus bear ACh receptors on action takes place at the site of the their surface, and may serve as a source of neuromuscular junction and motor endplate. autoantigen to trigger the autoimmune reaction within the thymus gland when an immunologic Risk Factors abnormality causes a breakdown an Disorders associated with an increased autoimmune attack on acetylcholine (ACh) incidence of MG are thymic disorders such as receptors.3 3 hyperthyroidism, thymic tumor, or thyrotoxicosis. There is an association with Clinical Manifestations diabetes and immune disorders such as Although MG encompasses a spectrum rheumatoid arthritis or lupus. Exacerbations of mild to severe, its cardinal features are may occur before the menstrual period or skeletal muscle weakness and fatigability. shortly after pregnancy. Chronic infections of Repetition of activity causes fatigue, whereas any kind can exacerbate MG. Five to seven rest restores activity. Other than weakness, percent appear to have a familial association. neurologic findings are normal. A system of four major categories is used to classify MG: ocular, Pathogenesis mild generalized, acute fulminating, or late In MG, the fundamental defect is at the severe. neuromuscular junction. Receptors at the motor The distribution of muscle weakness has endplate normally receive acetylcholine (ACh) a dichotomous pattern affecting only the ocular from the motor nerve terminal. An action muscles, or a more variable, generalized pattern potential occurs that leads to a muscle occurs. In approximately 8 5 % of persons with contraction. In MG the number of ACh receptors MG, the weakness i s generalized and affects the are decreased and those that remain are limb musculature. This fluctuating weakness is severity of the disease. However, in a person often more noticeable in proximal muscles. with MG a treatment-induced fall in the Cranial muscles, particularly the eyelids antibody level often correlates with clinical and the muscles controlling eye movements, are improvement. the first to show weakness. Diplopia (double The drug edrophonium (Tensilon) is used vision) and ptosis (drooping eyelids) are to demonstrate improvement in the myasthenic common early signs causing the person to tilt muscles by inhibiting acetylcholinesterase the head back to see (Fig. 3 9 - 1 8 ) . Weak neck (AChE), an enzyme required for ACh uptake. muscles may cause head bobbing in this Muscle strength and endurance are measured position. before and after administration of the drug. This Chewing of meat produces fatigue, and test confirms that ACh uptake is part of the the facial expression is one that seems to be pathologic status; however, a control test of snarling because the lips do not close. Speech saline should also be used for comparison. tends to be nasal. Difficulty in swallowing may Electrophysiologic testing of myasthenic occur as a result of palatal, pharyngeal, and disorders demonstrates a normal EMG at rest. tongue weakness. Nasal regurgitation or Specialized testing must be employed using aspiration of food is common. repetitive stimulation to demonstrate a rapid decrement in the motor action potential's MEDICAL MANAGEMENT amplitude. Absence of sensory deficits and DIAGNOSIS. History and clinical observation of retention of tendon reflexes throughout the symptoms of weakness with continued use and course of the disease also tend to confirm the improvement with rest are important in diagnosis of MG. Because respiratory diagnosing MG. Several conditions that cause impairment is a serious complication of MG, weakness of cranial, or somatic, muscles must measurements of ventilatory function should be also be considered. These include drug-induced performed.1 58 myasthenia, hyperthyroidism, botulism, intracranial mass lesions, and progressive TREATMENT. AChE inhibitor medication disorders of the eye. Lambert-Eaton syndrome is provides for improvement of weakness but does a presynaptic disorder of the neuromuscular not treat the underlying disease. Administration junction that can cause symptoms similar to of this medication is tailored to the individual's those of MG. Lambert-Eaton syndrome is an requirements throughout the day. For example, autoimmune disorder associated with neoplasm, a person with difficulty chewing and swallowing most commonly small cell (oat cell) carcinoma of would take the medication before meals. Side the lung, which is believed to trigger the effects of AChE inhibitors include autoimmune response. gastrointestinal effects such as nausea and The three methods used to diagnose MG vomiting, abdominal cramping, and increased are (1) immunologic, (2) pharmacologic, and (3) bronchial and oral secretions. electrophysiologic testing.1 0 5 Immunologic Surgical removal of the thymus is testing detects anti-ACh receptor antibodies in successful in 8 5 % of persons with MG. Up to 3 the serum. The presence of anti-ACh receptor 5 % of those undergoing thymectomy achieve a antibodies is virtually diagnostic of MG, but a drug-free remission, although this may take negative test does not exclude diagnosis of the years. disease. There is no correlation between the Immunosuppression using drugs, such as amount of anti-ACh receptor antibodies and the corticosteroids (prednisone) and azathioprine, are effective in nearly all persons with MG. 4C: Impaired Muscle Performance Initially, high daily doses are begun and then Physical and occupational therapy may followed by alternate-day high doses that are be indicated as supportive care to assist the tapered slowly over a period of months. client with MG. In the acute care setting, the Unfortunately, adverse side effects are therapist must establish an accurate neurologic associated with high-dose steroids. These and respiratory baseline. Tidal volume, vital include cushingoid appearance, weight gains, capacity, and inspiratory force should be hypertension, and osteoporosis (see Chapter 7 ). monitored regularly during treatment. Deep Plasmapheresis is performed to remove breathing and coughing should be encouraged. substances that affect ACh receptors. However, When eating, the person should be instructed to plasmapheresis produces only short-term sit upright and to swallow when the chin is reduction in anti-AChE antibodies and is not tipped slightly downward toward the chest and effective for long-term symptom control. never with the neck extended because of the risk of aspiration. Finally, the client should never PROGNOSIS. The course of MG is variable, speak with food in the mouth. typified by remissions and exacerbations, The therapist must also be alert to signs especially within the first year after onset. of an impending myasthenic crisis (increasing Symptoms often fluctuate in intensity during the muscle weakness; respiratory distress; or day. This daily variability is superimposed on difficulty while talking, chewing, or swallowing). longer-term spontaneous relapses that may last Make sure the client recognizes the side effects for weeks. Remissions are rarely complete or and signs of toxicity of AChE inhibitor permanent. This disorder follows a slowly medications. For those receiving a prolonged progressive course. Onset of other systemic course of corticosteroids, report adverse side disorders and infections may precipitate an effects to the physician. exacerbation of the disease and are the most Plan therapy and teach the client to plan common cause of a crisis. A myasthenic crisis is activities to coincide with periods of maximum a medical emergency requiring attention to life- energy (see Box 9-8 for energy conservation endangering weakening of the respiratory tips). The home should be arranged to help muscles. A myasthenic crisis requires ventilator prevent unnecessary energy expenditure. assistance. Treatment of a crisis occurs in the Frequent rest periods help conserve energy and ICU because the client requires careful, give muscles a chance to regain strength. The immediate control of medications for survival.1 person with MG should avoid strenuous 78 exercise, stress, and excessive exposure to the When MG begins in children, it is sun or cold weather. All of these can exacerbate important to establish the form it takes. Because signs and symptoms. AChE antibodies cross the placenta, 1 0% of Researchers report that a strength newborns of mothers with MG develop a training program eliciting maximal isometric myasthenic reaction. Newborns with neonatal contractions could be instituted in clients with MG have a weak suck and cry and are hypotonic. mild-to-moderate MG. As long as participants Fortunately, this resolves in a few weeks. were monitored for fatigue during periods of exercise, improvements were noted in all SPECIAL IMPLICATIONS FOR THE PT 39-10 muscles.9 3 After 3 months, participants' knee Myasthenia Gravis extensor muscles showed the most significant PREFERRED PRACTICE PATTERNS strength gains without adverse reactions. Recently, a cooling vest was worn to decrease core body temperature to determine whether pulmonary function and subjective perceptions of strength and fatigue would improve. All measures were improved in the majority of participants.1 0 7 Because individuals diagnosed as having MG are placed on long-term corticosteroid medication, the treatment may induce a secondary condition: osteoporosis. These individuals should be encouraged to undergo dual energy x-ray absorptiometry (previously DEXA, now DXA) scan and to receive calcium supplements to counteract osteoporosis.91 The Myasthenia Gravis Foundation ( 800- 541-5454 ) publishes educational materials that can be helpful to the client and family.